We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Guidelines for Treating Severe Traumatic Brain Injury

By HospiMedica staff writers
Posted on 09 Jul 2007
New Guidelines for the management of severe traumatic brain injury (TBI) have been released by The Brain Trauma Foundation's (BTF, New York, NY, USA).

The third edition of the guidelines, which include specific recommendations with regard to monitoring intracranial pressure (ICP) and brain tissue oxygen (BtO2) management, were developed by the BTF in association with the American Association of Neurological Surgeons (AANS), the Congress of Neurological Surgeons (CNS), and the AANS/CNS Joint Section on Neurotrauma and Critical Care. More...
The 2007 guidelines incorporate the latest published research findings relevant to the diagnosis and treatment of severe traumatic brain injury.

"Research has shown that not all brain damage occurs at the moment of impact. Damage frequently evolves over the ensuing hours and days after the initial injury,” said BTF president Jamshid Ghajar, M.D., Ph.D., FACS, a clinical professor of neurological surgery at Weill Cornell Medical College (New York, NY, USA). "Research has proven that, in most cases, this secondary damage can be controlled using scientific, evidence-based treatment guidelines.”

The Brain Trauma Foundation was founded in 1986 as a non-profit organization to improve outcomes for TBI patients. TBI, usually from car crashes but also falls and sport injuries, is the leading cause of death and disability in children and young adults. The BTF is dedicated to improving TBI care during the acute phase after injury, in the
ambulance and in the hospital. By educating medical professionals in this area, thousands of lives could be saved each year in the United States and thousands more could be spared lifelong permanent disabilities.


Related Links:
The Brain Trauma Foundation's

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.